Expanding the Aesthetic Medicine Business Through the Business Alliance with SBC Medical Group
First written in FY2022-Q3. 9 of 13 entries say "Advanced", first in FY2022. Latest entry: 2026-08-20.
1 other company's latest entry also says "First stated".
- FY2025AdvancedAnnual report
「We steadily increased the number of partner clinics by using sales agencies suited to regional characteristics to acquire new partner clinics.」
The company expanded partner clinics through personnel investment and sales agencies tailored to regional characteristics. - FY2025-H1AdvancedAnnual report
「We strengthened the sales organization through optimal personnel allocation and additional hiring and worked to deepen relationships with partner clinics. As a result, outsourced processing orders in orthopedics and AGA treatment have grown steadily, including reaching a record high since services began in March.」
In the medical-aesthetic and regenerative-medicine fields, processing orders in orthopedics and AGA reached a record high. - FY2024RestatedAnnual report
「For outsourced blood-derived processing services, we will actively propose introductions focused not only on orthopedic clinics, but also on clinics and other facilities in the AGA, or male-pattern baldness, field.」
The company continues to expand blood-derived processing services from orthopedics into AGA clinics. - FY2023-Q2AdvancedAnnual report
「In the Medical Support business, we actively promoted proposals to introduce blood-derived processing (CPRP-FD) to orthopedic clinics and other facilities nationwide.」
The company used the alliance as a base to expand CPRP-FD proposals nationwide and increase partner medical institutions. - FY2023-Q1AdvancedAnnual report
「On 18 November 2022, we entered into a business alliance agreement with SBC Medical Group Co., Ltd., represented by Yoshiyuki Aikawa, our major and largest shareholder.」
The company entered into a business alliance with SBC Medical Group, adding outsourced operation and management and sales activities for a cell-processing center (CPC) and joint development of an ordering system for regenerative medicine. - FY2022AdvancedAnnual report
「We will roll out nationwide outsourced services for blood-derived processing and adipose-derived stem-cell processing by combining the respective strengths of SBC Medical Group and the Group.」
The alliance expanded beyond collaborative products and cross-selling into clinic advertising and outsourced cell-processing services for regenerative medicine. - FY2022-Q3First statedAnnual report
「We will expand sales of our core original HADA NATURE brand to SBC Medical Group Co., Ltd., procure various medical-aesthetic products held by SBC Medical Group Co., Ltd. and sell them directly to consumers through our e-commerce sites and other channels. We will also jointly develop and sell collaborative products combining SBC Medical Group’s advanced expertise in medical aesthetics with our planning capabilities in cosmetics.」
The business alliance covers HADA NATURE sales, procurement and e-commerce sales of medical-aesthetic products, and joint development and sales using both companies’ strengths.